Lantheus: FDA Accepts For Filing ANDA For Generic Version Of LUTATHERA

Lantheus Holdings, Inc. (LNTH) said its Abbreviated New Drug Application for Lutetium Lu 177 Dotatate or Lu-PNT2003, a generic version of LUTATHERA, has been accepted for filing by the FDA.

Related Keywords

,Robot Corp ,International Labor Organization ,Labor Department ,European Commission ,World Employment ,Social Outlook Trends ,Fda ,Lantheus Holdings ,